UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
Current Report
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact Name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation) |
(Commission File Number) | (I.R.S. Employer Identification No.) |
(Address of principal executive offices) (Zip Code)
Registrant’s
telephone number, including area code:
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading symbol(s) | Name of each exchange on which registered | ||
| NONE | NONE | NONE |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Chief Financial Officer Appointment
On February 23, 2023, after the untimely passing of its Chief Financial Officer, the board of directors (the “Board”) of Blonder Tongue Laboratories, Inc. (the “Company”) appointed Michael Censoplano to Interim Chief Financial Officer of the Company, effective immediately (the “CFO Appointment”).
Michael Censoplano, Interim CFO
Michael Censoplano, 50, has been with the Company for over 22 years, serving as the Company Controller since January 2001, and as the assistant controller from July 2000 through December 2000. Michael has an undergraduate degree from Rider University.
Family Relationships
Mr. Censoplano does not have a family relationship with any of the current officers or directors of the Company.
Related Party Transactions
There are no related party transactions with regard to Mr. Censoplano reportable under Item 404(a) of Regulation S-K.
Compensatory Arrangements
Mr. Censoplano shall receive an annual salary of $111,728.24 and as a full-time employee of the Company, will be eligible to participate in all of the Company’s benefit programs.
Item 7.01 Regulation FD Disclosure
On February 23, 2023, the Company issued a press release announcing the CFO Appointment. A copy of the press release is attached hereto as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
| Exhibit No. | Description | |
| 99.1* | Press Release issued on February 23, 2023 | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |
| * | Filed herewith. |
1
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| BLONDER TONGUE LABORATORIES, INC. | ||
| By: | /s/ Edward R. Grauch | |
| Edward R. Grauch | ||
| Chief Executive Officer and President | ||
Date: March 1, 2023
2
Exhibit 99.1
BLONDER TONGUE ANNOUNCES DEATH OF SENIOR VICE PRESIDENT AND CHIEF FINANCIAL OFFICER ERIC SKOLNIK
Old Bridge, N.J. – February 23, 2023 – It is with great sadness that Blonder Tongue Laboratories, Inc. (OTCQB: BDRL) Board of Directors announce the death of Senior Vice President and Chief Financial Officer, Eric S. Skolnik. He was 58.
“Eric was a most trusted friend and business colleague,” says Bob Palle, incoming CEO of Blonder Tongue. “Eric cared for each and every person that makes up the Blonder Tongue family. Eric’s tireless work ethic and caring nature would lighten your workload and brighten your outlook following any interaction with him. We loved Eric. Our hearts are with his family at this difficult time. May he rest in peace.”
Eric joined Blonder Tongue as the Corporate Controller starting in May 2000, and quickly rose to become Chief Financial Officer in May 2001. He was promoted to Senior Vice President in 2003, the position he held for the last 20 years, as well as serving on Blonder Tongue’s Board of Directors as Secretary, and also Treasurer. He previously worked as a certified public accountant with BDO USA, LLP. A graduate of Rutgers University, Mr. Skolnik held a Bachelor of Science degree in Accounting.
Michael Censoplano has been appointed Interim CFO. More announcements will follow as details become available.
ABOUT BLONDER TONGUE
Blonder Tongue Laboratories, Inc. is the oldest designer and manufacturer of telecommunications and cable television video transmission technology in the USA. The majority of our products continue to be designed and built in our state-of-the-art New Jersey facility, which has been the Company’s home for more than 50 years. Blonder Tongue Labs offers U.S.-based engineering and manufacturing excellence with an industry reputation for delivering ultra-high reliability products. As a leader in cable television system design, the Company provides service operators and systems integrators with comprehensive solutions for the management and distribution of digital video, IPTV and high-speed data services, as well as RF broadband distribution over fiber, IP, and Coax networks for homes and businesses. Additional information on the Company and its products can be found at www.blondertongue.com
CONTACTS
Liz Rapelye
Senior Director, Marketing, Sales & Service
lrapelye@blondertongue.com
732-679-4000
Cover |
Feb. 23, 2023 |
|---|---|
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Feb. 23, 2023 |
| Entity File Number | 001-14120 |
| Entity Registrant Name | Blonder Tongue Laboratories, Inc. |
| Entity Central Index Key | 0001000683 |
| Entity Tax Identification Number | 52-1611421 |
| Entity Incorporation, State or Country Code | DE |
| Entity Address, Address Line One | One Jake Brown Road |
| Entity Address, City or Town | Old Bridge |
| Entity Address, State or Province | NJ |
| Entity Address, Postal Zip Code | 08857 |
| City Area Code | (732) |
| Local Phone Number | 679-4000 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Entity Emerging Growth Company | false |